Chemfab Alkalis Intrinsic Value
Chemfab Alkalis (CHEMFAB) median intrinsic value is ₹265.25 from 4 valuation models (range ₹162–₹271), vs current price ₹404.70 — -34.5% downside (Trading Above Calculated Value), margin of safety -52.6%. For current market price and key ratios, visit CHEMFAB share price.
CHEMFAB Valuation Methods Summary — DCF, Graham Number & P/E
Chemfab Alkalis intrinsic value across 4 models vs current price ₹404.70 — upside/downside and value range per method. Browse CHEMFAB balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹271.43 | ₹244.29 - ₹298.57 | -32.9% | Book Value/Share: ₹271.43, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹178.29 | ₹160.46 - ₹196.12 | -55.9% | Revenue/Share: ₹222.86, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹161.88 | ₹145.69 - ₹178.07 | -60.0% | EBITDA: ₹28.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹265.25 | ₹212.20 - ₹318.30 | -34.5% | CF Growth: 5.0%, Discount: 15% |
CHEMFAB Intrinsic Value vs Market Price — All Valuation Models
Chemfab Alkalis fair value range ₹162–₹271 vs current market price ₹404.70 across 4 valuation models. Compare with CHEMFAB DCF to assess whether the stock is under or overvalued.
CHEMFAB Intrinsic Value Analysis — Undervalued or Overvalued?
Chemfab Alkalis median intrinsic value ₹265.25, current price ₹404.70 — Trading Above Calculated Value by 34.5%, margin of safety -52.6%.
What is the intrinsic value of CHEMFAB?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Chemfab Alkalis (CHEMFAB) is ₹265.25 (median value). With the current market price of ₹404.70, this represents a -34.5% variance from our estimated fair value.
The valuation range spans from ₹161.88 to ₹271.43, indicating ₹161.88 - ₹271.43.
Is CHEMFAB undervalued or overvalued?
Based on our multi-method analysis, Chemfab Alkalis (CHEMFAB) appears to be trading above calculated value by approximately 34.5%.
CHEMFAB Financial Health — Key Ratios vs Industry Benchmarks
Chemfab Alkalis financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.70 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -2.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.60x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CHEMFAB Cash Flow Quality — Operating & Free Cash Flow
Chemfab Alkalis operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹40 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹31 Cr | ₹-24 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹93 Cr | ₹69 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹55 Cr | ₹45 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹45 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |